Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP520352.RAP2xR8rcTruWdeY17eVeELRBPQT8pUwyifP_6OZa_5r8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP520352.RAP2xR8rcTruWdeY17eVeELRBPQT8pUwyifP_6OZa_5r8130_assertion type Assertion NP520352.RAP2xR8rcTruWdeY17eVeELRBPQT8pUwyifP_6OZa_5r8130_head.
- NP520352.RAP2xR8rcTruWdeY17eVeELRBPQT8pUwyifP_6OZa_5r8130_assertion description "[Recently, a cirrhosis risk score (CRS) based on seven single-nucleotide polymorphisms was proposed as genetic predictor of cirrhosis in hepatitis C. To assess the role of CRS in predicting fibrosis progression in patients with initially no or minimal to moderate fibrosis, we investigated 271 untreated patients with chronic hepatitis C having initial liver biopsy showing METAVIR stage F0 (n = 104), F1 (n = 101), or F2 (n = 59) who had been followed up without antiviral therapies for at least 60 months (mean 108.5 +/- 71.5 months) and had a liver biopsy at the end of this observation period.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP520352.RAP2xR8rcTruWdeY17eVeELRBPQT8pUwyifP_6OZa_5r8130_provenance.
- NP520352.RAP2xR8rcTruWdeY17eVeELRBPQT8pUwyifP_6OZa_5r8130_assertion evidence source_evidence_literature NP520352.RAP2xR8rcTruWdeY17eVeELRBPQT8pUwyifP_6OZa_5r8130_provenance.
- NP520352.RAP2xR8rcTruWdeY17eVeELRBPQT8pUwyifP_6OZa_5r8130_assertion SIO_000772 19676127 NP520352.RAP2xR8rcTruWdeY17eVeELRBPQT8pUwyifP_6OZa_5r8130_provenance.
- NP520352.RAP2xR8rcTruWdeY17eVeELRBPQT8pUwyifP_6OZa_5r8130_assertion wasDerivedFrom befree-20140225 NP520352.RAP2xR8rcTruWdeY17eVeELRBPQT8pUwyifP_6OZa_5r8130_provenance.
- NP520352.RAP2xR8rcTruWdeY17eVeELRBPQT8pUwyifP_6OZa_5r8130_assertion wasGeneratedBy ECO_0000203 NP520352.RAP2xR8rcTruWdeY17eVeELRBPQT8pUwyifP_6OZa_5r8130_provenance.